Cargando…

Natural history of LGMD2A for delineating outcome measures in clinical trials

OBJECTIVE: Limb‐girdle muscular dystophy 2A (LGMD2A, OMIM) is a slowly progressive myopathy caused by the deficiency in calpain 3, a calcium‐dependent cysteine protease of the skeletal muscle. METHODS: In this study, we carried out an observational study of clinical manifestations and disease progre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richard, Isabelle, Hogrel, Jean‐Yves, Stockholm, Daniel, Payan, Christine A. M., Fougerousse, Françoise, Eymard, Bruno, Mignard, Claude, Lopez de Munain, Adolfo, Fardeau, Michel, Urtizberea, Jon Andoni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818744/ https://www.ncbi.nlm.nih.gov/pubmed/27081656 http://dx.doi.org/10.1002/acn3.287

Ejemplares similares

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome
por: Blandin, Gaëlle, et al.
Publicado: (2013)

Iranian neurological events: The second Iranian congress of neuromuscular disorders
por: Urtizberea, Jon Andoni
Publicado: (2012)

LGMD. Identification, description and classification
por: Angelini, Corrado
Publicado: (2020)

Metabolic Myopathies in the Era of Next-Generation Sequencing
por: Urtizberea, Jon Andoni, et al.
Publicado: (2023)

Disease Progression and Mutation Pattern in a Large Cohort of LGMD R1/LGMD 2A Patients from India
por: Ganaraja, Valakunja H., et al.
Publicado: (2021)

Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study
por: Willis, Tracey A., et al.
Publicado: (2013)

LGMD2I in a North American population
por: Kang, Peter B, et al.
Publicado: (2007)

Tail properties and approximate distribution and expansion for extreme of LGMD
por: Huang, Jianwen, et al.
Publicado: (2017)

PROCEEDINGS OF LGMD days MEETING: Prognosis and Treatment in LGMD October 15-17, 2014 IRCCS "S. Camillo", Lido di Venezia (VE), Italy
Publicado: (2014)

Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1
por: Hogrel, Jean‐Yves, et al.
Publicado: (2017)

Extensive morphological and immunohistochemical characterization in myotubular myopathy
por: Shichiji, Minobu, et al.
Publicado: (2013)

A Journey with LGMD: From Protein Abnormalities to Patient Impact
por: Georganopoulou, Dimitra G., et al.
Publicado: (2021)

Current and Future Approaches to Classify VUSs in LGMD-Related Genes
por: Li, Chengcheng, et al.
Publicado: (2022)

Marathons and myasthenia gravis: a case report
por: Birnbaum, Simone, et al.
Publicado: (2018)

Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery
por: Carotti, Marcello, et al.
Publicado: (2020)

The sensitivity of exome sequencing in identifying pathogenic mutations for LGMD in the United States
por: Reddy, Hemakumar M., et al.
Publicado: (2016)

Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing
por: Yu, Meng, et al.
Publicado: (2017)

Genetic Counseling and NGS Screening for Recessive LGMD2A Families
por: Strafella, Claudia, et al.
Publicado: (2020)

Enhancing LGMD-based model for collision prediction via binocular structure
por: Zheng, Yi, et al.
Publicado: (2023)

Ankle dorsi- and plantar-flexion torques measured by dynamometry in healthy subjects from 5 to 80 years
por: Moraux, Amélie, et al.
Publicado: (2013)

Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D
por: Sandell, Satu, et al.
Publicado: (2016)

Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T)
por: Oestergaard, S.T., et al.
Publicado: (2016)

Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Finsterer, Josef
Publicado: (2018)

Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits
por: Thiruvengadam, Girija, et al.
Publicado: (2021)

Next-Generation Sequencing Identifies Transportin 3 as the Causative Gene for LGMD1F
por: Torella, Annalaura, et al.
Publicado: (2013)

LGMD phenotype due to a new gene and dysferlinopathy investigated by next-generation sequencing
por: Angelini, Corrado I.
Publicado: (2015)

Lithium chloride corrects weakness and myopathology in a preclinical model of LGMD1D
por: Findlay, Andrew R., et al.
Publicado: (2019)

LGMD D2 TNPO3-Related: From Clinical Spectrum to Pathogenetic Mechanism
por: Costa, Roberta, et al.
Publicado: (2022)

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy: A GRASP-LGMD study
por: Doody, Amy, et al.
Publicado: (2023)

Redox State and Mitochondrial Respiratory Chain Function in Skeletal Muscle of LGMD2A Patients
por: Nilsson, Mats I., et al.
Publicado: (2014)

RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice
por: Liu, Jian, et al.
Publicado: (2014)

Next generation sequencing on patients with LGMD and nonspecific myopathies: Findings associated with ANO5 mutations
por: Savarese, Marco, et al.
Publicado: (2015)

The Author Reply: Genotypic and Phenotypic Heterogeneity of LGMD1D due to DNAJB6 Mutations
por: Kim, Kitae, et al.
Publicado: (2018)

Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients
por: Nallamilli, Babi Ramesh Reddy, et al.
Publicado: (2018)

Clinical Delineation and Natural History of the PIK3CA-Related Overgrowth Spectrum**
por: Keppler-Noreuil, Kim M, et al.
Publicado: (2014)

Wrist flexion and extension torques measured by highly sensitive dynamometer in healthy subjects from 5 to 80 years
por: Decostre, Valérie, et al.
Publicado: (2015)

Differential expression profiling between the relative normal and dystrophic muscle tissues from the same LGMD patient
por: Zhang, Yong, et al.
Publicado: (2006)

Unveiling the degradative route of the V247M α-sarcoglycan mutant responsible for LGMD-2D
por: Bianchini, Elisa, et al.
Publicado: (2014)

Duchenne muscular dystrophy–like phenotype in an LGMD2I patient with novel FKRP gene variants
por: Okazaki, Tetsuya, et al.
Publicado: (2020)

Therapeutic Benefit of Galectin-1: Beyond Membrane Repair, a Multifaceted Approach to LGMD2B
por: Vallecillo-Zúniga, Mary L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hhv28t0pa8tunfoba87gq3ka2l